Global News

Phase I Doesn’t Faze Them

Wednesday, October 25, 2006

It was interesting to see Waltham, Mass.-based Parexel, a global contract research organization (CRO), remaining unfazed in the hot phase I clinical research market. Earlier this month, Parexel agreed to acquire California Clinical Trials and Behavioral and Medical Research for $65 million. A key part of the deal is a 51-bed phase I unit that would boost Parexel’s presence in the phase I market.

[Read More]

Smaller EMR Companies Could Push Integration

Tuesday, October 17, 2006

The use of electronic medical records (EMR) technology to enhance the conduct and efficiency of clinical trials has been highly touted of late. The ability to utilize hospital medical records in patient recruitment is seen as a promising solution to costly subject recruitment delays. Companies operating in the EMR space are looking for ways to integrate their systems to work togther with established eClinical infrasture. Aside from a few of the global IT giants such as Siemen AG and Oracle Clinical, GE Healthcare and McKesson, some of the smaller players in EMR may be the ones to watch out for. Being smart, quick and nimble has a big advantage in the IT idustry.

[Read More]

In India, A Pairing Born Of Necessity

Monday, October 9, 2006

India’s clinical research market entered a new era in January 2005 with the signing of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. TRIPS requires the country to honor all product patents issued after 1995.

[Read More]

Painless Growth?

Monday, October 9, 2006

Big Pharma continues to expand into the vaccine market as Pfizer purchased privately owned PowderMed this week, hoping for an ouch-free entry into this segment. The vaccine market is suddenly looking golden to Big Pharma when just a few years ago it seemed that most drugmakers wouldn’t go near vaccines.

[Read More]

The Psychology of Clinical Trials: Understanding Physician Motivation and Patient Perception

Wednesday, October 4, 2006

The clinical trials industry has been at the center of public scrutiny following recent news reports of unethical patient recruitment and manipulated trial results. Are these well-publicized stories causing doctors and patients to shy away from experimental treatment? What are the key factors that drive physicians to refer patients into clinical trials and what are patients’ biggest concerns?

To gain a better understanding of the psychology of the clinical trials patient and referring physician, CenterWatch conducted a series of in-depth doctor and patient surveys. The results and related observations, which were presented this June at the Drug Information Association Annual Meeting, are outlined in this CenterWatch Research Brief…

[Read More]